The latest plan by 23andMe co-founder and CEO Anne Wojcicki to acquire the genetic testing company was rejected by a special ...

Experts say the CEO’s second attempt to buy back the troubled DNA startup comes with a slew of corporate governance red flags ...

Me (ME) gained 3% after its CEO Anne Wojcicki made a non-binding revised offer of $2.94 a share for the genetic testing ...

23andMe CEO Anne Wojcicki is attempting to buy her company back for a mere $42 million. It’s a fraction of the company’s ...

Wojcicki's onetime partner in a potential buyout deal backed out Friday, but on Sunday she submitted a new acquisition plan. The latest plan by 23andMe co-founder and CEO Anne Wojcicki to acquire ...

Me’s special committee of independent directors on Monday rejected CEO Anne Wojcicki’s proposal to take the distressed ...

The genetic testing giant's CEO just made a desperate $2.94/share bid--after its stock cratered 99%. Will the board bite?

23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the company private. They are offering to buy all outstanding shares in cash for $2.53 per share, or an equity ...

The CEO has joined forces with venture capital firm New Mountain Capital in the bid to take the company private ...

23andMe (ME) rose 3% after its CEO Anne Wojcicki made a non-binding revised offer of $2.94 a share for the genetic testing company. Under her latest proposal, Wojcicki offered upfront cash ...

A saliva collection kit for DNA testing that comes from 23andMe. From the San Francisco Business Times. The latest plan by 23andMe co-founder and CEO Anne Wojcicki to acquire the genetic testing ...